Plasma Metabolome Signatures to Predict Responsiveness to Neoadjuvant Chemotherapy in Breast Cancer.
Álex Aparecido Rosini SilvaMarcella Regina CardosoDanilo Cardoso de OliveiraPedro Henrique Godoy SanchesMaria Cecília Ramiro TalaricoJunier Marrero GutierrezRaquel M Rodrigues PeresLucas Miguel CarvalhoNatália Angelo da Silva MiyagutiLuis O SarianAlessandra TataSophie Françoise Mauricette DerchainAndreia Melo PorcariPublished in: Cancers (2024)
We developed a model for predicting patient response to NACT. These metabolite panels allow clinical gain by building precision medicine strategies based on tumor stratification.